Multi-center anal pre-cancer treatment and cancer prevention study launched in HIV-infected persons

NCI has launched a multicenter phase III clinical trial called the ANCHOR Study — Anal Cancer HSIL (High-grade Squamous Intraepithelial Lesion) Outcomes Research Study — to determine if treatment of HSIL in HIV-infected individuals can prevent anal cancer from developing. …read more

Source:: Cancer